The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Amlodipine/Valsartan Mylan

Mylan Pharmaceuticals LimitedEU/1/16/1092/027-039

Main Information

Trade NameAmlodipine/Valsartan Mylan
Active SubstancesAmlodipine besilate
Dosage FormFilm-coated tablet
Licence HolderMylan Pharmaceuticals Limited
Licence NumberEU/1/16/1092/027-039

Group Information

ATC CodeC09DB Angiotensin II antagonists and calcium channel blockers
C09DB01 valsartan and amlodipine


License statusAuthorised
Licence Issued22/03/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0042-084-003
Interchangeable List DocumentPDF of Interchangeable List
« Back